Rexahn Pharmaceuticals

(NSC:REXN) Trade

Symbol has changed to a new ticker symbol


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Rexahn Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is dedicated to the discovery, development, and commercialization of treatments for cancer. Its mission is to improve the lives of cancer patients by developing next-generation cancer therapies that are designed to maximize efficacy while minimizing the toxicity and side effects traditionally associated with cancer treatment. Rexahn has developed three clinical-stage drug candidates: RX-3117, Supinoxin (RX-5902) and Archexin. RX-3117 is a small molecule nucleoside compound with an anti-metabolite mechanism of action.

Contact Information

Main Phone: +1 240 268-5300
Address: 15245 Shady Grove Road
Address 2: Suite 455
State: MD
City / Town: Rockville
Country: US
Postal Code: 20850

Issuer Information

Exchange: NSC
CEO: Douglas J. Swirsky
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A